PRKDC and osteosarcoma: Persistent activation of the DNA-PKcs/AKT pathway is linked to the chemoresistance of osteosarcoma cells, and the hypothesis is that eicosapentaenoic acid (EPA) may downregulate this pathway, thereby promoting ferroptosis in response to cisplatin treatment (Zhang Y. et al., 2023).